No disclosed counterparties: TKO, LYV.
| Stage | TKO | % of rev | LYV | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.5B | 100.00% | $7.7B | 100.00% | LYV ×4.96 |
| Gross profit | $1.5B | 100.00% | $1.9B | 25.34% | TKO +74.7pp |
| Operating income | $430M | 27.78% | $522M | 6.81% | TKO +21.0pp |
| Pre-tax income | $362M | 23.37% | $519M | 6.76% | TKO +16.6pp |
| Net income | $304M | 19.65% | $403M | 5.25% | TKO +14.4pp |
| Stage | TKO | LYV | Gap · A − B |
|---|---|---|---|
| Revenue | $1.5B100.00% | $7.7B100.00% | LYV ×4.96 |
| Gross profit | 100.00%$1.5B | 25.34%$1.9B | TKO +74.7pp |
| Operating income | 27.78%$430M | 6.81%$522M | TKO +21.0pp |
| Pre-tax income | 23.37%$362M | 6.76%$519M | TKO +16.6pp |
| Net income |
| 19.65%$304M |
| 5.25%$403M |
| TKO +14.4pp |